High PSA Does Not Always Mean Prostate Cancer: What Men Should Know About PSA and Screening

An elevated PSA (prostate-specific antigen) is a worrying sign and it’s common in prostate and oncology clinics for specialists to have consultations from a lot of patients who are apprehensive about their raised PSA levels and conclude that they have prostate cancer. Often they are false alarms. But at the same time, an elevated PSA may indicate some problems with the prostate.

The purpose of PSA testing is therefore not to create unnecessary alarm but to identify men who may need further evaluation and, when cancer is present, help detect it at a stage when treatment is more likely to be effective. It’s quite often that men are diagnosed at later stages, when the aggressive malignancy has increased treatment complexity and reduced the favourability of the outcomes.

So, let’s rephrase:

What Every Man Should Know About PSA

• Prostate cancer may have no symptoms in its early stages. The absence of urinary or other symptoms does not necessarily mean that the prostate is healthy.
• A raised PSA does not automatically mean cancer. Benign prostate enlargement, inflammation and infection can also increase PSA.
• Early detection can make a significant difference. Localized prostate cancer has excellent survival outcomes.
• Screening should be individualized. Age, family history, previous PSA results and other risk factors should be considered when deciding whether and when to undergo screening.

Men should discuss prostate cancer screening with their doctors, particularly as they approach the age at which screening may be appropriate for them. Men at higher risk may need to discuss screening earlier.

Does a High PSA Mean You Have Prostate Cancer?

Does a high PSA immediately mean you have prostate cancer? That’s not true at all. First, let’s understand what PSA is: PSA stands for prostate-specific antigen, a protein produced by both normal and cancerous prostate cells. A PSA test measures the amount of this protein in the blood.

PSA is useful because changes in its level can provide information about prostate health but it isn’t a cancer-specific test. PSA can increase for a number of reasons, including benign prostate enlargement, inflammation, infection and prostate cancer. That’s why a PSA result is never interpreted in isolation. Doctors consider the result alongside factors such as age, prostate size, urinary symptoms, medical history, previous PSA measurements and individual risk factors.

A PSA level within the expected range also does not completely rule out prostate cancer. The result is one part of a broader assessment of prostate health.

Why Can PSA Be Elevated?

Benign Prostate Enlargement
The prostate commonly increases in size with age, a condition known as benign prostatic hyperplasia (BPH). A larger prostate can produce more PSA and may also cause urinary symptoms such as a weak urine stream and frequent or urgent urination. BPH is not prostate cancer, although both conditions can occur in the same person.

Prostatitis and Prostate Inflammation
Inflammation or infection of the prostate, known as prostatitis, can cause PSA levels to rise. The increase may be temporary and can decrease after the underlying inflammation or infection has settled. When appropriate, a doctor may recommend treating the underlying condition and repeating the PSA test after an appropriate interval.

Prostate Cancer
Cancerous changes in the prostate can also increase PSA. However, PSA alone cannot establish whether cancer is present.

An elevated result should therefore lead to appropriate evaluation rather than an immediate conclusion of cancer.

Prostate Cancer Can Be Silent. Consider Early Screening

One of the reasons prostate cancer screening is important is that early prostate cancer often does not cause noticeable symptoms. Urinary symptoms such as difficulty urinating, a weak stream or frequent urination are often attributed to prostate cancer, but they are more commonly associated with benign prostate enlargement. Some men with prostate cancer may have no urinary symptoms at all.

When symptoms such as blood in the urine or semen, pain in the back, hips or pelvis, or significant urinary changes occur, they should be medically evaluated. But it’s not recommended to wait for symptoms before considering prostate cancer screening either, but rather to take proactive measures if you fall into any of the at-risk categories. Screening decisions should be based on factors such as age, family history, previous PSA results and individual risk.

Who Is at Higher Risk of Prostate Cancer?

Risk is not the same for every man. A discussion about screening may be particularly important for men with factors such as:

• A close family history of prostate cancer
• A known genetic predisposition associated with increased prostate cancer risk
• Other individual risk factors identified by a healthcare professional

Men at increased risk may be advised to discuss screening at a younger age than men at average risk. Rather than following a single age threshold for everyone, screening is best approached as an individualized decision that accounts for the risk factors.

What Happens If Your PSA Is High?

An elevated PSA does not automatically mean that you need a biopsy, nor does it confirm that you have prostate cancer.

The next step depends on the individual clinical picture. Your doctor may:

1. Review previous PSA results to assess whether the level is stable or changing over time.
2. Review your medical history and risk factors, including family history and previous prostate problems.
3. Assess urinary or other symptoms and perform an appropriate clinical examination.
4. Repeat the PSA test when appropriate, particularly if there is a possibility that the elevation is temporary.
5. Use additional PSA-based or other tests to further assess the likelihood of clinically significant prostate cancer.
6. Recommend prostate imaging, particularly a multiparametric MRI (mpMRI), when indicated.
7. Consider a prostate biopsy if the overall assessment suggests that cancer needs to be ruled out.

The point is that a PSA result is generally the starting point for evaluation.

Does Every Man With a High PSA Need a Biopsy?

Not at all. A prostate biopsy involves taking small tissue samples from the prostate so they can be examined under a microscope for cancer.

Whether a biopsy is necessary depends on the overall assessment rather than the PSA number alone. Factors such as the PSA level and its pattern over time, prostate examination findings, risk factors, and imaging results may all influence the decision.

Multiparametric MRI (mpMRI) can provide detailed images of the prostate and may help identify areas that are more suspicious for clinically significant cancer. When a biopsy is required, MRI findings can also help guide the sampling of suspicious areas.

This approach can help avoid unnecessary biopsies in some men while ensuring that men with a significant likelihood of prostate cancer receive appropriate investigation.

Why Early Detection Matters

Prostate cancer is one of the most common cancers affecting men. It develops when abnormal cells in the prostate grow and multiply in an uncontrolled manner.

Importantly, prostate cancer does not always produce symptoms in its early stages. By the time symptoms become apparent, the disease may already be more advanced.

When prostate cancer is detected while it remains localized to the prostate, treatment outcomes are generally excellent. Current U.S. cancer statistics report a five-year relative survival rate of more than 99% for localized and regional prostate cancer. This is why screening and appropriate evaluation of abnormal PSA results can have an important role in identifying clinically significant disease earlier.

Prostate Care at RIVEA

A prostate cancer diagnosis can involve complex decisions about further testing, monitoring and treatment. The right approach depends on the stage and characteristics of the disease, as well as the individual patient’s health, risk factors and preferences.

At RIVEA Prostate Clinic, care is focused on helping patients understand their diagnosis, assess their options and make informed decisions based on current evidence and their individual needs.

Our multidisciplinary prostate care includes:

• Prostate cancer screening and early detection
• Advanced prostate imaging and diagnostic evaluation
• Second opinions and diagnostic review
• Active surveillance for appropriately selected patients
• Individualized treatment planning and coordination
• Long-term follow-up and survivorship care

Whether you are undergoing routine screening, being evaluated for an elevated PSA, have received a prostate cancer diagnosis, or require ongoing surveillance, our approach is designed to provide care at every stage of prostate health.